Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e54615cae7fbdeb71f90ae0dccf624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66406059e1e9bcea4832a0c25e5dcf84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c3384a5eb1a3d9038d7c218dca54f05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92077d261916c1e573ccfa091715daa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6bb402cfb5650e6356d50ac406389e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97cd61e716b699b600d64f1a893ffc9e |
publicationDate |
2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2015203160-A1 |
titleOfInvention |
Immuno-based botulinum toxin serotype A activity assays |
abstract |
CANRPorthl\DCC\GRSW733134_ I DOC-1I /2012 IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS The present invention is directed to a pharmaceutical composition comprising botulinum neurotoxin serotype A (BoNT/A), wherein the potency during manufacture of the pharmaceutical is specifically determined. |
priorityDate |
2008-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |